MedTrace Logo

Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment

NCT05080569 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1008

Last updated 2025-12-31

No results posted yet for this study

Summary

The LUMO study is a multicenter, randomized controlled trial that evaluates the effectivity of luteal phase support in MOH/IUI treatment.

Conditions

  • Pregnancy Related
  • Fertility Issues
  • Luteal Phase Defect
  • Infertility Unexplained

Interventions

DRUG

Progesterone Vaginal Product

3dd200mg

DRUG

Placebo

3dd1 vaginal capsule

Sponsors & Collaborators

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Broekmans, Prof. Dr. · Professor Reproductive Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2025-12-31
Completion
2027-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080569 on ClinicalTrials.gov